Syn-Coll (Palmitoyl Tripeptide-5) – 200MG

Scientific Overview of Syn-Coll

Syn-Coll, also referred to as Palmitoyl Tripeptide-5 or Tripeptide-5, is a synthetic peptide designed as an analogue to the extracellular matrix protein thrombospondin-1 (TSP-1). TSP-1 is naturally present in connective tissues and is associated with collagen and elastin maintenance. Syn-Coll has been studied for its potential to replicate some of the biological signaling roles attributed to TSP-1, particularly in the context of transforming growth factor-beta (TGF-β) activity. Research interest in Syn-Coll has centered on its possible influence over collagen balance in skin models, where it may encourage protein synthesis and help slow protein degradation. The compound has been explored in laboratory systems to understand how small synthetic peptides might mimic complex extracellular signals relevant to tissue structure and organization.

Alternative Names: Palmitoyl Tripeptide-5, Tripeptide-5

Syn-Coll Studies and Research Data

Syn-Coll Investigations into Collagen Dynamics

Experimental findings suggest Syn-Coll may interact with signaling pathways linked to TGF-β, a growth factor thought to play a key role in collagen synthesis. Some reports propose that Syn-Coll may support type I and type III collagen production while simultaneously limiting degradation through interactions with enzymes such as matrix metalloproteinases. By potentially restraining these enzymes, the peptide appears to provide a model for examining ways to maintain extracellular matrix stability.

Explorations of Skin Surface Changes

Laboratory observations have noted that Syn-Coll may be associated with smoother, more uniform tissue appearance under test conditions. Controlled investigations propose that the compound might influence surface properties such as wrinkle visibility and roughness. In some experiments, Syn-Coll was reported to outperform comparison peptides in terms of measured changes to skin models, with results suggesting incremental improvements when observed over multiple weeks.

Syn-Coll Research on Modified Variants

In addition to Syn-Coll itself, scientists have synthesized derivatives by coupling the peptide with other compounds. One such modification involved linking Syn-Coll with an ascorbic acid analogue, aiming to improve stability and activity. This variant was studied for potential contributions to collagen generation and pigment regulation in cellular systems. Findings suggest that such modifications may expand the scope of Syn-Coll research into areas such as oxidative stress and pigmentation processes.

Role of TSP-1 Signaling Models

Since Syn-Coll is considered a synthetic counterpart of thrombospondin-1, studies have examined its relationship to wound repair and postnatal tissue development pathways. TSP-1 is known to influence activation of latent TGF-β, which in turn may regulate the formation of collagen-rich structures. Laboratory models propose that Syn-Coll may reproduce some of these interactions, thereby offering a simplified system for studying complex protein signaling in extracellular environments.

Conclusion

Syn-Coll is a synthetic tripeptide modeled on thrombospondin-1 and investigated for its potential influence on collagen-related processes. Research has highlighted its possible interactions with TGF-β signaling, its capacity to both encourage collagen production and limit degradation, and its exploratory use in studies of wrinkle visibility and skin structure. Additional work has examined derivatives of Syn-Coll that may further expand its experimental relevance. Collectively, findings suggest that Syn-Coll serves as a valuable model compound in the study of extracellular matrix regulation and peptide-based research.

References

1. Schneider, A. L. (2010). Evaluation of the penetration and efficacy of topical anti-aging compounds (Doctoral dissertation, Monash University).
2. Murphy-Ullrich, J. E., & Poczatek, M. (2000). Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology. Cytokine & Growth Factor Reviews, 11(1–2), 59–69.
3. Trookman, N. S., Rizer, R. L., Ford, R., Ho, E., & Gotz, V. (2009). Immediate and long-term clinical benefits of a treatment for facial lines and wrinkles. The Journal of Clinical and Aesthetic Dermatology, 2(3), 38–43.
4. Kim, H. M., An, H. S., Bae, J. S., Kim, J. Y., Choi, C. H., Kim, J. Y., Lim, J. H., Choi, J. H., Song, H., Moon, S. H., Park, Y. J., Chang, S. J., & Choi, S. Y. (2017). Effects of palmitoyl-KVK-L-ascorbic acid on skin wrinkles and pigmentation. Archives of Dermatological Research, 309(5), 397–402.
5. Varga, J., Rosenbloom, J., & Jimenez, S. A. (1987). Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. The Biochemical Journal, 247(3), 597–604.
6. Gorouhi, F., & Maibach, H. I. (2009). Role of topical peptides in preventing or treating aged skin. International Journal of Cosmetic Science, 31(5), 327–345.
7. Errante, F., Ledwoń, P., Latajka, R., Rovero, P., & Papini, A. M. (2020). Cosmeceutical peptides in the framework of sustainable wellness economy. Frontiers in Chemistry, 8, 572923.
8. Schagen, S. K. (2017). Topical peptide treatments with effective anti-aging results. Cosmetics, 4(2), 16.
9. Thorsen, M., Yde, B., Pedersen, U., Clauden, K., & Lawesson, S. O. (1983). Studies on amino acids and peptides-V: Syntheses of endothionated melanostatin analogs. Tetrahedron, 39(20), 3429–3435.
10. Bucay, V. W., & Day, D. (2013). Adjunctive skin care of the brow and periorbital region. Clinics in Plastic Surgery, 40(1), 225–236.

Disclaimer:
The products mentioned are intended solely for laboratory research and in-vitro experimentation. They are not approved for human or animal use of any kind. All details provided are for educational purposes only. By purchasing from this site, you agree to comply with our Terms and Conditions.